Phase lb/ll study of the PI3Kα inhibitor BYL719 in combination with cetuximab in recurrent/metastatic squamous cell cancer of the head and neck (SCCHN).Albiruni R. A. Razak,Myung-Ju Ahn,Chia-Jui Yen,Benjamin J. Solomon,Se-Hoon Lee,Hung-Ming Wang,Pamela N. Munster,Carla M.L.- Van Herpen,Jill Gilbert, Rupam Ranjan Pal,Lars Blumenstein, Belen Gomez-Carrillo,Christina Marie Coughlin,Wan-Teck LimJournal of Clinical Oncology（2014）引用 16|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
